Europe Equine Healthcare Market Size, Share, Trends, Industry Analysis Report: By Product, Indication, Activity, Distribution Channel, and Country

Description

List of Tables

The Europe equine healthcare market size is expected to reach USD 1,959.48 million by 2032, according to a new study by Polaris Market Research. The report "Europe Equine Healthcare Market Size, Share, Trends, Industry Analysis Report: By Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Orthobiologics, Software, and Others), Indication, Activity, Distribution Channel, and Country - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The equine healthcare market in Europe is experiencing significant growth, driven by various factors such as the expansion of veterinary services, increasing awareness of equine health, and rising incidences of equine diseases. Higher disease prevalence leads to a stronger emphasis on preventive care, such as parasite control, vaccinations, and biosecurity measures. This drives demand for the products and services aimed at disease prevention. Thus, the high prevalence of equine diseases propels the Europe equine healthcare market growth.

The high prevalence of equine diseases in Europe, along with the rising equestrian activities, drives the equine healthcare market. Growing equestrian activities and higher disease prevalence focus a stronger emphasis on equine related services such as preventive care and others, thereby driving market. For instance in June 2020, Germany has reported an outbreak of equine infectious anaemia (EIA) affecting one equid (presumably a horse) in the federal state of Hesse in Western Germany.

Europe Equine Healthcare Market Report Highlights

In terms of activity, the sports/racing segment accounted for the largest market share in 2023, owing to the growing popularity of equestrian sports and competitive racing across Europe.

The recreation segment is expected to witness the highest growth during the forecast period, owing to the rise in recreational riding and leisure activities

Based on product, the pharmaceuticals segment accounted for the largest market share in 2023, owing to the persistent demand for advanced treatments for common equine conditions such as respiratory infections and musculoskeletal issues.

The software segment is projected to grow at a robust pace in the coming years because of the increasing integration of digital technologies in equine healthcare management.

The UK accounted for a major market share in 2023. The market growth in the country is attributed to the growing emphasis on recreational riding and the increasing number of leisure horses. Furthermore, the increasing incidence of equine influenza, West Nile virus, and tetanus diseases among horses in the UK boosts the country's market growth.

The market in Germany is projected to register the fastest growth during the forecast period, attributable to its well-established equestrian industry and robust healthcare infrastructure. Additionally, Germany's advanced veterinary research institutions and high standards of care contribute to its market growth.

Zoetis Services LLC; Arthrex Inc.; Dechra; Ceva Sante Animale; Merck & Co., Inc.; Heska Corporation; Hallmarq Veterinary Imaging; ESAOTE SPA; Vetoquinol S.A.; IDEXX Laboratories, Inc.; Elanco; Covetrus Inc.; Cargill; and Biosig Instruments Inc. are among the European market players.

Polaris Market Research has segmented the Europe equine healthcare market report on the basis of product, indication, activity, distribution channel, and country:

By Product Outlook (Revenue, USD million, 2019-2032)

Vaccines
Pharmaceuticals
Parasiticides
Anti-infectives
Anti-inflammatory & Analgesics
Other Pharmaceuticals
Medicinal Feed Additives
Orthobiologics
Diagnostics
Diagnostic Test Kits
Diagnostic Equipment
Software
Practice Management Software
Imaging Software
Telehealth Software
Other Software
Other

By Indication Outlook (Revenue, USD million, 2019-2032)

Musculoskeletal Disorders
Parasitic Infections
Equine Herpes Virus
Equine Viral Arteritis (EVA)
Equine Influenza
West Nile Virus
Tetanus
Other

By Activity Outlook (Revenue, USD million, 2019-2032)

Sports/Racing
Recreation
Other

By Distribution Channel Outlook (Revenue, USD million, 2019-2032)

Veterinary Hospitals & Clinics
E-commerce
Equestrian Facilities
Other

By Country Outlook (Revenue, USD million, 2019-2032)

Germany
UK
France
Italy
Spain
Switzerland
Sweden
Netherland
Russia
Rest of Europe

Product Code: PM5064

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Europe Equine Healthcare Market Insights

4.1. Europe Equine Healthcare Market - Market Snapshot
4.2. Europe Equine Healthcare Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing horse population is driving the market
  - 4.2.1.2. Growing government funding and initiatives propels the market
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Lack of skilled professionals is hindering the market growth
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Europe Equine Healthcare Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Europe Equine Healthcare Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Europe Equine Healthcare Market, by Product, 2019-2032 (USD million)
5.3. Vaccines
- 5.3.1. Europe Equine Healthcare Market, by Vaccines, by Country, 2019-2032 (USD million)
5.4. Pharmaceuticals
- 5.4.1. Europe Equine Healthcare Market, by Pharmaceuticals, by Country, 2019-2032 (USD million)
5.5. Medicinal Feed Additives
- 5.5.1. Europe Equine Healthcare Market, by Medicinal Feed Additives, by Country, 2019-2032 (USD million)
5.6. Orthobiologics
- 5.6.1. Europe Equine Healthcare Market, by Orthobiologics, by Country, 2019-2032 (USD million)
5.7. Diagnostics
- 5.7.1. Europe Equine Healthcare Market, by Diagnostics, by Country, 2019-2032 (USD million)
5.8. Software
- 5.8.1. Europe Equine Healthcare Market, by Software, by Country, 2019-2032 (USD million)
5.9. Other
- 5.9.1. Europe Equine Healthcare Market, by Other, by Country, 2019-2032 (USD million)

6. Europe Equine Healthcare Market, by Indication

6.1. Key Findings
6.2. Introduction
- 6.2.1. l Europe Equine Healthcare Market, by Indication, 2019-2032 (USD million)
6.3. Musculoskeletal Disorders
- 6.3.1. Europe Equine Healthcare Market, by Musculoskeletal Disorders, by Country, 2019-2032 (USD million)
6.4. Parasitic Infections
- 6.4.1. Europe Equine Healthcare Market, by Parasitic Infections, by Country, 2019-2032 (USD million)
6.5. Herpes Virus
- 6.5.1. Global Europe Equine Healthcare Market, by Equine Herpes Virus, by Country, 2019-2032 (USD million)
6.6. Equine Viral Arteritis (EVA)
- 6.6.1. Europe Equine Healthcare Market, by Equine Viral Arteritis (EVA), by Country, 2019-2032 (USD million)
6.7. Equine Influenza
- 6.7.1. Europe Equine Healthcare Market, by Equine Influenza, by Country, 2019-2032 (USD million)
6.8. West Nile Virus
- 6.8.1. Europe Equine Healthcare Market, by West Nile Virus, by Country, 2019-2032 (USD million)
6.9. Tetanus
- 6.9.1. Europe Equine Healthcare Market, by Tetanus, by Country, 2019-2032 (USD million)
6.10. Other
- 6.10.1. l Europe Equine Healthcare Market, by Other, by Country, 2019-2032 (USD million)

7. Europe Equine Healthcare Market, by Activity

7.1. Key Findings
7.2. Introduction
- 7.2.1. Europe Equine Healthcare Market, by Activity, 2019-2032 (USD million)
7.3. Sports/Racing
- 7.3.1. Europe Equine Healthcare Market, by Sports/Racing, by Country, 2019-2032 (USD million)
7.4. Recreation
- 7.4.1. Europe Equine Healthcare Market, by Recreation, by Country, 2019-2032 (USD million)
7.5. Other
- 7.5.1. Europe Equine Healthcare Market, by Other, by Country, 2019-2032 (USD million)

8. Europe Equine Healthcare Market, by Distribution Channel

8.1. Key Findings
8.2. Introduction
- 8.2.1. Europe Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD million)
8.3. Veterinary Hospitals & Clinics
- 8.3.1. Europe Equine Healthcare Market, by Veterinary Hospitals & Clinics, by Country, 2019-2032 (USD million)
8.4. E-commerce
- 8.4.1. Europe Equine Healthcare Market, by E-commerce, by Country, 2019-2032 (USD million)
8.5. Equestrian Facilities
- 8.5.1. Europe Equine Healthcare Market, by Equestrian Facilities, by Country, 2019-2032 (USD million)
8.6. Other
- 8.6.1. Europe Equine Healthcare Market, by Other, by Country, 2019-2032 (USD million)

9. Europe Equine Healthcare Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Europe Equine Healthcare Market Assessment, By Geography, 2019-2032 (USD million)
9.3. Europe Equine Healthcare Market - Europe
- 9.3.1. Europe: Equine Healthcare Market, by Product, 2019-2032 (USD million)
- 9.3.2. Europe: Equine Healthcare Market, by Indication, 2019-2032 (USD million)
- 9.3.3. Europe: Equine Healthcare Market, by Activity, 2019-2032 (USD million)
- 9.3.4. Europe: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD million)
- 9.3.5. Europe Equine Healthcare Market - UK
  - 9.3.5.1. UK: Equine Healthcare Market, by Product, 2019-2032 (USD million)
  - 9.3.5.2. UK: Equine Healthcare Market, by Indication, 2019-2032 (USD million)
  - 9.3.5.3. UK: Equine Healthcare Market, by Activity, 2019-2032 (USD million)
  - 9.3.5.4. UK: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD million)
- 9.3.6. Europe Equine Healthcare Market - France
  - 9.3.6.1. France: Equine Healthcare Market, by Product, 2019-2032 (USD million)
  - 9.3.6.2. France: Equine Healthcare Market, by Indication, 2019-2032 (USD million)
  - 9.3.6.3. France: Equine Healthcare Market, by Activity, 2019-2032 (USD million)
  - 9.3.6.4. France: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD million)
- 9.3.7. Europe Equine Healthcare Market - Germany
  - 9.3.7.1. Germany: Equine Healthcare Market, by Product, 2019-2032 (USD million)
  - 9.3.7.2. Germany: Equine Healthcare Market, by Indication, 2019-2032 (USD million)
  - 9.3.7.3. Germany: Equine Healthcare Market, by Activity, 2019-2032 (USD million)
  - 9.3.7.4. Germany: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD million)
- 9.3.8. Europe Equine Healthcare Market - Italy
  - 9.3.8.1. Italy: Equine Healthcare Market, by Product, 2019-2032 (USD million)
  - 9.3.8.2. Italy: Equine Healthcare Market, by Indication, 2019-2032 (USD million)
  - 9.3.8.3. Italy: Equine Healthcare Market, by Activity, 2019-2032 (USD million)
  - 9.3.8.4. Italy: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD million)
- 9.3.9. Europe Equine Healthcare Market - Spain
  - 9.3.9.1. Spain: Equine Healthcare Market, by Product, 2019-2032 (USD million)
  - 9.3.9.2. Spain: Equine Healthcare Market, by Indication, 2019-2032 (USD million)
  - 9.3.9.3. Spain: Equine Healthcare Market, by Activity, 2019-2032 (USD million)
  - 9.3.9.4. Spain: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD million)
- 9.3.10. Europe Equine Healthcare Market - Netherlands
  - 9.3.10.1. Netherlands: Equine Healthcare Market, by Product, 2019-2032 (USD million)
  - 9.3.10.2. Netherlands: Equine Healthcare Market, by Indication, 2019-2032 (USD million)
  - 9.3.10.3. Netherlands: Equine Healthcare Market, by Activity, 2019-2032 (USD million)
  - 9.3.10.4. Netherlands: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD million)
- 9.3.11. Europe Equine Healthcare Market - Russia
  - 9.3.11.1. Russia: Equine Healthcare Market, by Product, 2019-2032 (USD million)
  - 9.3.11.2. Russia: Equine Healthcare Market, by Indication, 2019-2032 (USD million)
  - 9.3.11.3. Russia: Equine Healthcare Market, by Activity, 2019-2032 (USD million)
  - 9.3.11.4. Russia: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD million)
- 9.3.12. Europe Equine Healthcare Market - Rest of Europe
  - 9.3.12.1. Rest of Europe: Equine Healthcare Market, by Product, 2019-2032 (USD million)
  - 9.3.12.2. Rest of Europe: Equine Healthcare Market, by Indication, 2019-2032 (USD million)
  - 9.3.12.3. Rest of Europe: Equine Healthcare Market, by Activity, 2019-2032 (USD million)
  - 9.3.12.4. Rest of Europe: Equine Healthcare Market, by Distribution Channel, 2019-2032 (USD million)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Zoetis Services LLC
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Arthrex Inc.
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Dechra
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. Ceva Sante Animale
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Merck & Co., Inc.
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Heska Corporation
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Hallmarq Veterinary Imaging
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. ESAOTE SPA
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Vetoquinol S.A
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. IDEXX Laboratories, Inc.
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Elanco
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Covetrus Inc
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. Cargill
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Biosig Instruments Inc.
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development